Skip to content

Nurix

Inside The Science
Advancing Our Pipeline
- Pipeline
- Clinical Trials
Learn About Us
Work at Nurix
- Our Culture
- Explore Jobs

Investors & News

Investors & News

Nurix

Inside The Science
Advancing Our Pipeline
- Pipeline
- Clinical Trials
Learn About Us
Work at Nurix
- Our Culture
- Explore Jobs

Sarah Cannon Research Institute UK, Limited

By wpengine / September 28, 2026

Third Rock Ventures and The Column Group Launch Nurix with $25.1 Million Financing to Target Key Regulatory Pathway

WHERE SCIENCE EXPANDS POSSIBILITIES

Inside The Science

DEL-AI Discovery Engine
Targeted Protein Degradation
Resource Library

Advancing Our Pipeline

Pipeline
Clinical Trials

Learn About Us

Our Story
Leadership
Partnering
Contact Us

Work at Nurix

Our Culture
Explore Jobs

For Investors

News & Events
Financial Information
Stock Information
Corporate Governance
FAQs
Investor Contact

For Patients

Resources

©2026 Nurix Therapeutics, Inc.

Data Privacy Framework Policy

Scientific Exchange Privacy Notice

You are now leaving the nurixtx.com website. This link will take you to a website to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website.

Cancel

Continue

hide2